1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Urology Imaging Equipment Market, By Type
5.1 Introduction
5.2 Receptor Tyrosine Kinase Inhibitors
5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)
5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)
5.2.3 Anaplastic lymphoma kinase (ALK)
5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)
5.2.5 Estimated Glomerular Filtration Rate (EGFR)
5.3 Non-receptor Tyrosine Kinase Inhibitors
5.3.1 BCR-ABL
5.3.2 Mesenchymal Epithelial Transition Growth Factor (c-MET)
5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors
5.3.4 Spleen Tyrosine Kinase (SYK) Inhibitors
5.3.5 Janus Kinase (JAK) Inhibitor
5.4 Serine/Threonine Kinase Inhibitors
5.5 RHO Kinase Inhibitors
5.6 Multikinase inhibitors
5.7 Protein Kinase C Inhibitors
5.8 X-ray/Fluoroscopy Imaging Systems
5.9 Endovision Systems
5.10 Urology Operating Tables
5.11 Ultrasound Systems
6 Global Urology Imaging Equipment Market, By Distribution Channel
6.1 Introduction
6.2 Independent Pharmacies
6.3 Hospital Pharmacies
6.4 Online Pharmacies
7 Global Urology Imaging Equipment Market, By Application
7.1 Introduction
7.2 Inflammatory Diseases
7.3 Oncology
7.3.1 Renal Cell Cancer
7.3.2 Lung Cancer
7.3.3 Breast Cancer
7.4 Diagnostics
7.5 Interventional
8 Global Urology Imaging Equipment Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Specialty Clinics
9 Global Urology Imaging Equipment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Bristol-Myers Squibb Company
11.2 Johnson & Johnson
11.3 Boehringer Ingelheim International GmbH
11.4 Novartis AG
11.5 Eisai Co., Ltd.
11.6 Bayer AG
11.7 AstraZeneca plc
11.8 Pfizer, Inc.
11.9 GE Healthcare (General Electric Company)
11.10 F. Hoffmann-La Roche Ltd
11.11 Stryker
11.12 Olympus Corporation
11.13 Siemens Healthineers
11.14 Richard Wolf GmbH
11.15 Boston Scientific Corporation
11.16 KARL STORZ
11.17 CANON MEDICAL SYSTEMS CORPORATION
11.18 Koninklijke Philips N.V.
11.19 Guerbet
List of Tables
Table 1 Global Urology Imaging Equipment Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Urology Imaging Equipment Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Urology Imaging Equipment Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 4 Global Urology Imaging Equipment Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)
Table 5 Global Urology Imaging Equipment Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)
Table 6 Global Urology Imaging Equipment Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)
Table 7 Global Urology Imaging Equipment Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)
Table 8 Global Urology Imaging Equipment Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)
Table 9 Global Urology Imaging Equipment Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 10 Global Urology Imaging Equipment Market Outlook, By BCR-ABL (2018-2027) ($MN)
Table 11 Global Urology Imaging Equipment Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)
Table 12 Global Urology Imaging Equipment Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)
Table 13 Global Urology Imaging Equipment Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)
Table 14 Global Urology Imaging Equipment Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)
Table 15 Global Urology Imaging Equipment Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)
Table 16 Global Urology Imaging Equipment Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)
Table 17 Global Urology Imaging Equipment Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)
Table 18 Global Urology Imaging Equipment Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)
Table 19 Global Urology Imaging Equipment Market Outlook, By X-ray/Fluoroscopy Imaging Systems (2018-2027) ($MN)
Table 20 Global Urology Imaging Equipment Market Outlook, By Endovision Systems (2018-2027) ($MN)
Table 21 Global Urology Imaging Equipment Market Outlook, By Urology Operating Tables (2018-2027) ($MN)
Table 22 Global Urology Imaging Equipment Market Outlook, By Ultrasound Systems (2018-2027) ($MN)
Table 23 Global Urology Imaging Equipment Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 24 Global Urology Imaging Equipment Market Outlook, By Independent Pharmacies (2018-2027) ($MN)
Table 25 Global Urology Imaging Equipment Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 26 Global Urology Imaging Equipment Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 27 Global Urology Imaging Equipment Market Outlook, By Application (2018-2027) ($MN)
Table 28 Global Urology Imaging Equipment Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)
Table 29 Global Urology Imaging Equipment Market Outlook, By Oncology (2018-2027) ($MN)
Table 30 Global Urology Imaging Equipment Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)
Table 31 Global Urology Imaging Equipment Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 32 Global Urology Imaging Equipment Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 33 Global Urology Imaging Equipment Market Outlook, By Diagnostics (2018-2027) ($MN)
Table 34 Global Urology Imaging Equipment Market Outlook, By Interventional (2018-2027) ($MN)
Table 35 Global Urology Imaging Equipment Market Outlook, By End User (2018-2027) ($MN)
Table 36 Global Urology Imaging Equipment Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 37 Global Urology Imaging Equipment Market Outlook, By Hospitals (2018-2027) ($MN)
Table 38 Global Urology Imaging Equipment Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
【免責事項】
https://www.marketreport.jp/reports-disclaimer